BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1662641)

  • 1. EPR-spectroscopy of reduced oxyferrous-P450cam.
    Davydov R; Kappl R; Hüttermann J; Peterson JA
    FEBS Lett; 1991 Dec; 295(1-3):113-5. PubMed ID: 1662641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific and non-specific effects of potassium cations on substrate-protein interactions in cytochromes P450cam and P450lin.
    Deprez E; Gill E; Helms V; Wade RC; Hui Bon Hoa G
    J Inorg Biochem; 2002 Sep; 91(4):597-606. PubMed ID: 12237225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Electron-conformational interactions at the active site of reduced bacterial cytochrome P450cam induced by a substrate and analysis of the electron structure of heme].
    Sharonov IuA
    Mol Biol (Mosk); 1992; 26(6):1251-62. PubMed ID: 1491671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPR studies on the photoproducts of ferric cytochrome P450cam (CYP101) nitrosyl complexes: effects of camphor and its analogues on ligand-bound structures.
    Masuya F; Tsubaki M; Makino R; Hori H
    J Biochem; 1994 Nov; 116(5):1146-52. PubMed ID: 7896745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectral intermediate in the reaction of ferrous cytochrome P450cam with superoxide anion.
    Kobayashi K; Iwamoto T; Honda K
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1348-55. PubMed ID: 8024579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate analogue induced changes of the CO-stretching mode in the cytochrome P450cam-carbon monoxide complex.
    Jung C; Hoa GH; Schröder KL; Simon M; Doucet JP
    Biochemistry; 1992 Dec; 31(51):12855-62. PubMed ID: 1463755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate induced changes of the active site electronic states in reduced cytochrome P450cam and the photolysis product of its CO complex. Low-temperature magnetic circular dichroism data.
    Greschner S; Sharonov YuA ; Jung C
    FEBS Lett; 1993 Jan; 315(2):153-8. PubMed ID: 8417971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced decomposition of oxyferrous cytochrome P450CIA1 (P450cam) by the chemopreventive agent 3-t-butyl-4-hydroxyanisole.
    Gettings SD; Brewer CB; Pierce WM; Peterson JA; Rodrigues AD; Prough RA
    Arch Biochem Biophys; 1990 Feb; 276(2):500-9. PubMed ID: 2154951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential behavior of the sub-sites of cytochrome 450 active site in binding of substrates, and products (implications for coupling/uncoupling).
    Narasimhulu S
    Biochim Biophys Acta; 2007 Mar; 1770(3):360-75. PubMed ID: 17134838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochrome P450cam: crystallography, oxygen activation, and electron transfer.
    Poulos TL; Raag R
    FASEB J; 1992 Jan; 6(2):674-9. PubMed ID: 1537455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of substrate on the spectral properties of oxyferrous wild-type and T252A cytochrome P450-CAM.
    Sono M; Perera R; Jin S; Makris TM; Sligar SG; Bryson TA; Dawson JH
    Arch Biochem Biophys; 2005 Apr; 436(1):40-9. PubMed ID: 15752707
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for compound I formation in the reaction of cytochrome P450cam with m-chloroperbenzoic acid.
    Egawa T; Shimada H; Ishimura Y
    Biochem Biophys Res Commun; 1994 Jun; 201(3):1464-9. PubMed ID: 8024592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resonance Raman investigations of Escherichia coli-expressed Pseudomonas putida cytochrome P450 and P420.
    Wells AV; Li P; Champion PM; Martinis SA; Sligar SG
    Biochemistry; 1992 May; 31(18):4384-93. PubMed ID: 1581294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resonance Raman and EPR investigations of the D251N oxycytochrome P450cam/putidaredoxin complex.
    Sjodin T; Christian JF; Macdonald ID; Davydov R; Unno M; Sligar SG; Hoffman BM; Champion PM
    Biochemistry; 2001 Jun; 40(23):6852-9. PubMed ID: 11389599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamics of protein-bound water in the heme domain of P450BM3 studied by high-pressure spectroscopy: comparison with P450cam and P450 2B4.
    Davydov DR; Hui Bon Hoa G; Peterson JA
    Biochemistry; 1999 Jan; 38(2):751-61. PubMed ID: 9888815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification and characterization of benzoate-para-hydroxylase, a cytochrome P450 (CYP53A1), from Aspergillus niger.
    Faber BW; van Gorcom RF; Duine JA
    Arch Biochem Biophys; 2001 Oct; 394(2):245-54. PubMed ID: 11594739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct observation of a novel perturbed oxyferrous catalytic intermediate during reduced putidaredoxin-initiated turnover of cytochrome P-450-CAM: probing the effector role of putidaredoxin in catalysis.
    Glascock MC; Ballou DP; Dawson JH
    J Biol Chem; 2005 Dec; 280(51):42134-41. PubMed ID: 16115886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the complexes formed by cytochrome P450cam with cytochrome b5 and putidaredoxin, two effectors of camphor hydroxylase activity.
    Rui L; Pochapsky SS; Pochapsky TC
    Biochemistry; 2006 Mar; 45(12):3887-97. PubMed ID: 16548516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethylbenzene hydroxylation by cytochrome P450cam.
    Filipovic D; Paulsen MD; Loida PJ; Sligar SG; Ornstein RL
    Biochem Biophys Res Commun; 1992 Nov; 189(1):488-95. PubMed ID: 1449498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cryoreduction EPR and 13C, 19F ENDOR study of substrate-bound substates and solvent kinetic isotope effects in the catalytic cycle of cytochrome P450cam and its T252A mutant.
    Kim SH; Yang TC; Perera R; Jin S; Bryson TA; Sono M; Davydov R; Dawson JH; Hoffman BM
    Dalton Trans; 2005 Nov; (21):3464-9. PubMed ID: 16234926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.